Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 October, 2018 15:14 IST
Strides Shasun receives USFDA approval for Efavirenz tablets
Source: IRIS | 14 Mar, 2018, 09.44AM
Comments  |  Post Comment

Strides Shasun today announced that it's wholly owned subsidiary Strides Pharma Global has received approval for Efavirenz Tablets USP, 600 mg from the United States Food & Drug Administration (US FDA). Efavirenz Tablet is generic version of Sustiva Tablets of Bristol-Myers Squibb Company.

According to IQVIA data, the US market for Efavirenz Tablets USP, 600 mg is approximately USD 115 Million and Strides is only the second generic company to get the approval for the product under the para IV route. The product will be manufactured at the company's Oral dosage facility at Bangalore and will be marketed by Strides Pharma Inc. in the US Market. Strides is launching the product immediately.

The company has 74 cumulative ANDA filings with USFDA of which 44 ANDAs have been approved as of date and 30 are pending approval.

Shares of the company gained Rs 7.55, or 1.12%, to trade at  Rs 683.30.  The total volume of shares traded  was  2,073 at the BSE (9.31 a.m., Wednesday).



Strides Pharma Science Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Zydus receives final approval from USFDA for Clobazam Tablets - 23-Oct-2018 15:01
Ahluwalia Contracts wins new orders of worth Rs 5.38 bn - 23-Oct-2018 11:58
PNB Housing Finance raises Rs 17.75 bn through commercial papers - 23-Oct-2018 10:22
White Organic Agro bags additional orders from Innovative Cuisine - 23-Oct-2018 10:16
Himachal Futuristic Communications secures order worth Rs 3.66 bn - 23-Oct-2018 10:07
Lupin gets nod for generic Triamcinolone Acetonide ointment - 23-Oct-2018 10:00
ITD Cementation India bags orders worth Rs 10.66 bn - 23-Oct-2018 09:35
Biocon, Mylan announce positive CHMP Opinion for Ogivri - 22-Oct-2018 10:28
Air cargo industry must grow 12.9% annually to achieve national aviation policy target: Study - 22-Oct-2018 10:05
Lupin announces positive CHMP opinion for NaMuscla - 22-Oct-2018 09:51
Tejas Networks bags Rs 1.11 bn order from Sterlite Technologies - 22-Oct-2018 09:45
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer